Zoetis Inc. (ZTS): Price and Financial Metrics


Zoetis Inc. (ZTS): $204.71

3.36 (+1.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ZTS POWR Grades


  • ZTS scores best on the Quality dimension, with a Quality rank ahead of 94.66% of US stocks.
  • The strongest trend for ZTS is in Momentum, which has been heading down over the past 48 weeks.
  • ZTS's current lowest rank is in the Momentum metric (where it is better than 55.81% of US stocks).

ZTS Stock Summary

  • ZTS has a market capitalization of $97,021,115,749 -- more than approximately 97.38% of US stocks.
  • ZTS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 269.4 -- higher than 89.18% of US-listed equities with positive expected earnings growth.
  • The price/operating cash flow metric for Zoetis Inc is higher than 89.62% of stocks in our set with a positive cash flow.
  • If you're looking for stocks that are quantitatively similar to Zoetis Inc, a group of peers worth examining would be MMM, SYK, CAT, GE, and BDX.
  • Visit ZTS's SEC page to see the company's official filings. To visit the company's web site, go to www.zoetis.com.

ZTS Valuation Summary

  • In comparison to the median Healthcare stock, ZTS's EV/EBIT ratio is 33.45% higher, now standing at 39.1.
  • ZTS's price/sales ratio has moved up 9.4 over the prior 104 months.
  • Over the past 104 months, ZTS's price/earnings ratio has gone down 12.5.

Below are key valuation metrics over time for ZTS.

Stock Date P/S P/B P/E EV/EBIT
ZTS 2021-08-31 13.1 22.3 50.8 39.1
ZTS 2021-08-30 13.2 22.4 51.1 39.3
ZTS 2021-08-27 13.0 22.2 50.6 38.9
ZTS 2021-08-26 13.0 22.2 50.7 39.0
ZTS 2021-08-25 13.1 22.3 50.8 39.0
ZTS 2021-08-24 13.1 22.3 50.9 39.1

ZTS Growth Metrics

  • The 3 year price growth rate now stands at 117.89%.
  • Its 4 year cash and equivalents growth rate is now at 189.04%.
  • Its 5 year revenue growth rate is now at 31.76%.
ZTS's revenue has moved up $1,073,000,000 over the prior 15 months.

The table below shows ZTS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 7,412 2,161 1,909
2021-03-31 7,012 2,118 1,774
2020-12-31 6,675 2,126 1,638
2020-09-30 6,542 1,990 1,663
2020-06-30 6,340 1,934 1,617
2020-03-31 6,339 1,814 1,611

ZTS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ZTS has a Quality Grade of B, ranking ahead of 94.64% of graded US stocks.
  • ZTS's asset turnover comes in at 0.537 -- ranking 74th of 677 Pharmaceutical Products stocks.
  • GERN, CEMI, and NEOG are the stocks whose asset turnover ratios are most correlated with ZTS.

The table below shows ZTS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.537 0.695 0.233
2021-03-31 0.518 0.694 0.219
2020-12-31 0.514 0.692 0.206
2020-09-30 0.525 0.696 0.212
2020-06-30 0.535 0.697 0.207
2020-03-31 0.559 0.695 0.209

ZTS Price Target

For more insight on analysts targets of ZTS, see our ZTS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $185.00 Average Broker Recommendation 1.52 (Moderate Buy)

ZTS Stock Price Chart Interactive Chart >

Price chart for ZTS

ZTS Price/Volume Stats

Current price $204.71 52-week high $210.10
Prev. close $201.35 52-week low $141.41
Day low $202.17 Volume 1,197,600
Day high $205.98 Avg. volume 1,794,078
50-day MA $203.28 Dividend yield 0.49%
200-day MA $176.40 Market Cap 97.02B

Zoetis Inc. (ZTS) Company Bio


Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets the products in approximately 45 countries, and sells the products in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. (Source:Wikipedia)


ZTS Latest News Stream


Event/Time News Detail
Loading, please wait...

ZTS Latest Social Stream


Loading social stream, please wait...

View Full ZTS Social Stream

Latest ZTS News From Around the Web

Below are the latest news stories about Zoetis Inc that investors may wish to consider to help them evaluate ZTS as an investment opportunity.

3 Quality Pet Stocks To Pick Up Before They Rally

As pet owners spend on the wellness of their fluffy companions, these three pet stocks will likely benefit further in the long run.

Tezcan Gecgil on InvestorPlace | September 20, 2021

COLL vs. ZTS: Which Stock Should Value Investors Buy Now?

COLL vs. ZTS: Which Stock Is the Better Value Option?

Yahoo | September 20, 2021

Veterinary IVF Market Detail Analysis focusing on Key Players like IVF Limited, Minitube Group, Ovagenix, Jorgensen Labs, Zoetis, NEOGEN | Forecasts 2021-2027

Overview of Global Veterinary IVF Market: An international Veterinary IVF Market report covers a Market overview and the growth prospects of the Market. The current environment of the Healthcare industry and the key trends determining the Market are presented in the

OpenPR | September 17, 2021

Companion Animal Health Market Swot Analysis by key players Zoetis, Nutreco, Merck

HTF MI introduce new research on Worldwide Companion Animal Health covering micro level of analysis by competitors and key business segments. The Worldwide Companion Animal Health explores comprehensive study on various segments like opportunities, size, development, innovation, sales and overall

OpenPR | September 16, 2021

Veterinary Vaccine Market Report- Growth Factors Details for Business Development | Zoetis, Boehringer Ingelheim

Global Veterinary Vaccine Market research study offers a complete analysis of critical aspects of the current market situation including market competition, segmentation, geographical progress, and dynamic factors during the forecast period. The Veterinary Vaccine Market report offers insights into the

OpenPR | September 15, 2021

Read More 'ZTS' Stories Here

ZTS Price Returns

1-mo 0.14%
3-mo 9.47%
6-mo 31.46%
1-year 30.30%
3-year 130.86%
5-year 310.13%
YTD 24.23%
2020 25.76%
2019 55.71%
2018 19.45%
2017 35.55%
2016 12.64%

ZTS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ZTS Dividend History

Continue Researching ZTS

Here are a few links from around the web to help you further your research on Zoetis Inc's stock as an investment opportunity:

Zoetis Inc (ZTS) Stock Price | Nasdaq
Zoetis Inc (ZTS) Stock Quote, History and News - Yahoo Finance
Zoetis Inc (ZTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7345 seconds.